Carregant...
How do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients?
High mortality and morbidity rates associated with severe infections in the critically ill continue to be a significant issue for the healthcare system. In view of the diverse and unique pharmacokinetic profile of drugs in this patient population, there is increasing use of therapeutic drug monitori...
Guardat en:
| Publicat a: | BMC Infect Dis |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4289211/ https://ncbi.nlm.nih.gov/pubmed/25430961 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-14-288 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|